Natural Hormone Replacement Therapy: The Five Things Sold Under That Name

By The HRT Index Editorial Team · Last verified: September 2026 Editorial research — not medically reviewed by a clinician. Educational only, not medical advice. Provider prices, policies, product claims, and availability checked September 1, 2026.

Natural hormone replacement therapy is not one treatment. It can mean FDA-approved body-identical hormones, conjugated estrogens, compounded hormone prescriptions, over-the-counter creams, or herbal supplements. Only the first two categories include FDA-approved medicines. The body-identical hormones many women mean—estradiol and micronized progesterone—already exist as FDA-approved prescriptions.

You may not have to leave the pharmacy to get what you're looking for.

What changes this answer for you: whether you still have a uterus · whether you need a form an FDA-approved product does not provide · an allergy to an inactive ingredient · whether your symptoms need systemic or local treatment · your insurance and state · and your history of breast or uterine cancer, blood clots, stroke, heart attack, liver disease, or unexplained bleeding.

Best for: women who want “natural” hormones and need to know what that word actually buys them. Not for you as an online starting point if: you have bleeding after menopause that has not been evaluated, possible pregnancy, a current or prior hormone-sensitive cancer, or a history of blood clots, stroke, or heart attack. Start with a clinician who can review your records and examine you.

The five things people call natural hormone replacement therapy

What gets sold under the name	What it actually is	Body-identical?	FDA status	Usual payment route
1. Body-identical hormones on the approved shelf	FDA-approved estradiol products, oral micronized progesterone, and an approved oral estradiol-plus-progesterone combination	Yes	FDA-approved finished products	May be covered; formulary and plan rules decide
2. Conjugated estrogens	Premarin and other conjugated-estrogen products	No; the mixture is not identical to human estradiol	FDA-approved finished products	May be covered; formulary and plan rules decide
3. Compounded “bioidentical” hormones	Patient-specific or outsourcing-facility preparations such as bi-est, tri-est, custom creams, troches, capsules, or pellets	Ingredients may match human hormones; that does not confer product approval	Not FDA-approved	Usually cash-pay; coverage is uncommon and plan-specific
4. OTC “natural hormone” creams	Products marketed with wild yam, progesterone, pregnenolone, estrogen, or hormone-balancing language	Depends on what is actually in the product	No FDA-approved OTC estrogen or progesterone therapy	Cash-pay
5. Herbal menopause supplements	Black cohosh, soy isoflavones, red clover, dong quai, evening primrose, maca, and similar products	No; these are not human hormones	Dietary supplements are not FDA-approved to treat menopause symptoms before sale	Cash-pay

Only categories 1 and 2 contain FDA-approved hormone medicines. Categories 3 through 5 can still be legal products in the right lane, but they do not inherit FDA approval from a plant source, a familiar hormone name, or a clinician's prescription.

The HRT Index is the independent decision resource for online menopause and HRT care — comparing telehealth providers on clinical legitimacy, care quality, medication fit, price transparency, and access, with every claim verified and dated, so women can choose the path that fits their situation before their first consult.

→ Check the phrase you were given in the “Natural” Decoder

Sources: FDA menopause guidance, FDA compounding questions and answers, and The Menopause Society on hormone therapy.

---

What does natural hormone replacement therapy actually mean?

Natural hormone replacement therapy is a marketing umbrella, not one FDA approval category or one standardized clinical treatment. It can point to an FDA-approved prescription, a compounded prescription, an unapproved topical drug, a cosmetic, or a supplement containing no hormone at all. The word tells you almost nothing about the finished product.

That's frustrating. It's also fixable in about four minutes.

Many women arrive with a clean mental model: there are natural hormones and synthetic hormones, and the natural ones are safer. That model is repeated constantly. It is also wrong in the exact place that can cost you money.

Here is the better model. It is a grid, not a line:

	FDA-approved finished product	Not FDA-approved as a finished product
Same molecular structure as a hormone the body makes	Estradiol patches, gels, sprays, tablets, and rings · micronized progesterone capsules · Bijuva	Compounded estradiol, progesterone, estriol, or testosterone preparations · most hormone pellets and troches sold for menopause
Different molecule or not a hormone at all	Conjugated estrogens · synthetic progestins	Herbal supplements and wild-yam products that contain no finished human hormone

Look at the top-left box. That is where “I want the same hormone my body made” lives. It is an FDA-approved box.

Your instinct was not wrong. Molecule, route, dose, and product do matter. You just had the wrong map of where those choices live.

---

What is the one question that cuts through every “natural HRT” claim?

Verify the finished product—not just the ingredient. FDA approval applies to a specific drug product, dosage form, strength, manufacturer, and labeling. It does not travel with an ingredient into every cream, capsule, troche, or pellet a pharmacy prepares.

This rule solves more confusion than any other sentence on this page, so we are going to repeat it:

A hormone may appear in an FDA-approved medicine. A different cream containing that hormone may still be a compounded, non-FDA-approved product. Both facts can be true, and the second fact is the one that governs what you are buying.

A live example of the ingredient-versus-product problem

During our September 1, 2026 product-page audit, Winona's body-cream FAQ said its active ingredients were FDA-approved while naming estriol. FDA states that it has not approved any drug containing estriol. Winona separately labels the body cream as compounded, which is the accurate finished-product category—but the FAQ wording still demonstrates the exact conflation this rule catches.

The question is not whether estradiol, progesterone, or another ingredient exists in an approved medicine somewhere. The question is: Is this exact finished product FDA-approved?

The honest admission, up front

“Natural” is not a useless word. But it is not enough information to make a treatment decision.

It may describe a molecule's structure. It may describe a raw-material source. It may describe a compounded prescription. It may describe a supplement that does not replace a hormone at all. Four different things, one adjective.

So we are not going to tell you “natural is meaningless.” That is dismissive, and it is not true. We are going to tell you what the word is standing in for—and give you better words.

When a general answer runs out

The right online HRT provider isn't the same for every woman — it depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state. Some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider — and to flag when online care isn't the right starting point — before your first consult.

Find the starting path that fits your situation →

Sources: FDA menopause guidance, FDA compounding questions and answers, and Winona's provider-published body-cream product page, checked September 1, 2026.

---

What do natural, bioidentical, body-identical, plant-based, and compounded mean?

“Bioidentical” and “body-identical” describe molecular structure. “Natural” and “plant-derived” describe source or marketing. “Compounded” describes how a pharmacy prepared the finished product. None of those words, by itself, tells you whether the exact product is FDA-approved.

Word	What it tells you	What it does not tell you
Natural	Usually a source story or marketing frame	FDA status, dose, purity, effectiveness, route, or fit
Bioidentical	In common clinical use, the hormone has the same molecular structure as one the human body makes	Whether the finished product is approved, compounded, correctly dosed, or appropriate for you
Body-identical	The same molecular idea as bioidentical, with less compounding-marketing baggage	The same gaps: product status, dose, route, evidence, and fit
Plant-derived	A plant precursor was used somewhere in manufacturing	How much processing occurred, whether the final molecule is human-identical, or whether the product is approved
Compounded	A pharmacy or outsourcing facility prepared a non-FDA-approved drug under federal compounding provisions	That the finished product was reviewed by FDA for safety, effectiveness, or quality
FDA-approved	FDA reviewed the exact finished drug product for its approved use and manufacturing controls	That the product is right for every person or every off-label use

Bioidentical does not mean compounded

This is the most expensive misunderstanding on the page because it can push a woman into a cash-pay custom program when the molecule she wants is already available through an ordinary prescription.

Estradiol is body-identical. Micronized progesterone is body-identical. FDA-approved products containing both exist. A clinician with prescribing authority can prescribe them, including a usual primary-care or gynecology clinician who is comfortable managing menopause.

“Bioidentical” started as a molecular description and became a business category. The molecule did not change. The marketing did.

Why some clinicians say body-identical instead

Same molecular idea, cleaner word. Some menopause clinicians use body-identical to separate the biological description from the commercial category called “compounded bioidentical hormone therapy.” It does not create a new class of drug. It simply keeps the molecule and the product status from being collapsed into one word.

The “Natural” Decoder

Use this table on any product page, clinic intake, jar, or prescription offer. It gives you the one question the marketing language did not answer.

Phrase you were given	What it actually tells you	Is there an FDA-approved version?	The question to ask before you pay
Bioidentical / body-identical	The molecule may match a human hormone	Yes for products containing estradiol or micronized progesterone; not every product using those words is approved	“What is the exact finished product, manufacturer, strength, and FDA status?”
Plant-derived	A plant precursor may have been used	Sometimes; source does not decide approval	“What finished molecule was manufactured, and is this exact product FDA-approved?”
Compounded / custom formulated	A pharmacy or outsourcing facility prepared it	The compounded product itself is not FDA-approved	“What documented need can an approved product not meet, and which pharmacy makes this?”
Bi-est / tri-est	A compounded estrogen mixture that includes estriol	No FDA-approved U.S. drug contains estriol	“Why is estriol medically needed for me, and how will dose and response be monitored?”
Troche	A dosage form that dissolves in the mouth	No FDA-approved menopause-hormone troche	“Why this route, what is the exact dose delivered, and which pharmacy compounds it?”
Pellet	A long-acting implant placed under the skin	No estradiol or testosterone pellet is FDA-approved specifically to treat menopause in women	“What is the approved indication, what happens if the dose is too high, and how is it reversed?”
Wild yam cream	Usually a botanical source of diosgenin	No; wild yam is not finished progesterone	“Does the label list actual progesterone and a strength, or only wild-yam extract?”
Natural progesterone cream	The phrase may describe an OTC claim or a compounded prescription	No FDA-approved OTC progesterone cream exists	“Is this a prescription compounded drug or an OTC product, and how many milligrams are in each dose?”
Phytoestrogen	A plant compound that can interact weakly with estrogen pathways	Not an FDA-approved substitute for menopausal hormone therapy	“What symptom is this meant to treat, and what human trial supports this exact product and dose?”
Conjugated estrogens	A mixture of estrogen compounds, not body-identical estradiol	Yes; several prescription products are FDA-approved	“Which exact product is this, what is its source, and why this mixture instead of estradiol?”
Prasterone / DHEA vaginal insert	A local prescription option for painful sex after menopause	Yes—Intrarosa is approved for its labeled local use	“Is my problem local vaginal symptoms, or do I need treatment for systemic symptoms too?”

You do not need to memorize this. Save the page, print the table, or take the final column into your appointment.

→ Not sure which phrase describes what you actually want? That is the normal place to be. The next useful step is not choosing a brand; it is matching your symptoms, route, history, insurance model, and state.

Get your personalized HRT starting path →

Sources: The Menopause Society on hormone therapy, Endocrine Society position statement, FDA menopause guidance, and FDA compounding questions and answers.

---

Where do FDA-approved body-identical hormones come from?

Body-identical estradiol and micronized progesterone are manufactured hormones. Plant-derived precursors may be used, but laboratory conversion and pharmaceutical manufacturing create the finished molecule and controlled dose. Premarin is the clearest counterexample to the idea that “natural source” automatically means “same hormone your body made.”

We want to show you this carefully because it reorganizes everything else.

The Premarin label paradox

Premarin's FDA-approved labeling describes its conjugated estrogens as obtained from natural sources and derived from pregnant mares' urine. The same labeling identifies sodium estrone sulfate and sodium equilin sulfate among the principal components. Equilin is not a human estrogen.

Now hold that next to estradiol. FDA-approved estradiol products contain 17β-estradiol—the same molecular form as human estradiol. They are manufactured prescription drugs with product-specific strengths, routes, indications, and labeling.

On Premarin's own FDA-approved label, “natural source” describes a product that is not body-identical. That is the paradox.

The product with the explicit natural-source story is animal-derived and does not match human estradiol. The body-identical option is manufactured.

If nobody explained that before, it is not your fault. It is genuinely counterintuitive.

So is Premarin bad?

No. Let us be fair about this.

Premarin is an FDA-approved prescription option with decades of clinical use and product-specific evidence. It is simply not body-identical estradiol.

If avoiding animal-derived hormones or choosing the same molecular form as human estradiol matters to you, ask whether an FDA-approved estradiol product is appropriate for your symptoms and history. That is a product-fit conversation, not a moral ranking.

What “made in a lab” actually means

Manufacturing is not contamination. A laboratory step is not a moral failure. The controlled manufacturing and FDA-reviewed labeling are why an approved product can tell you the exact strength, dosage form, route, instructions, and known risks for that finished product.

A jar with no verified drug identity or dose is not more natural. It is less knowable. That is a different quality, and it is not the one you want.

Sources: Premarin labeling on DailyMed, The Menopause Society on hormone therapy, and Endocrine Society position statement.

---

Does wild yam cream turn into progesterone in your body?

No. Wild yam contains diosgenin, which can be converted into steroid hormones through industrial chemistry. The human body does not perform that conversion. A topical wild-yam extract is not the same thing as finished progesterone and did not improve symptoms or hormone levels in a placebo-controlled menopause trial.

The chemistry is real, and it is a great story right up until the part that matters.

In the 1940s, Russell Marker developed an industrial route for turning diosgenin from Mexican yams into progesterone. That chemistry helped make steroid-hormone manufacturing scalable. But it uses chemical processing in a manufacturing plant. It does not happen after you rub a yam extract on your skin.

A randomized, placebo-controlled trial by Komesaroff and colleagues tested topical wild-yam extract in menopausal women. It found no meaningful difference in symptoms and no change in measured sex-hormone levels.

We will say the useful version:

Wild-yam extract and prescription progesterone may share a plant story. They are not the same product. The missing step is chemical conversion and pharmaceutical manufacturing—the exact step the marketing leaves out.

Micronized progesterone is actual progesterone. Wild-yam extract is not. Your skin cannot perform the factory step.

You were not being offered the “unnatural” option. You were being offered the finished hormone.

Sources: Memorial Sloan Kettering's wild-yam monograph and Komesaroff et al., Climacteric 2001.

---

Which natural hormones are FDA-approved in the United States?

FDA-approved body-identical estradiol is available as systemic patches, gels, sprays, tablets, and a systemic vaginal ring, plus low-dose local vaginal creams, tablets, inserts, and a ring. FDA-approved micronized progesterone is available as an oral capsule. An approved oral estradiol-plus-progesterone combination also exists.

This is the shelf. A large share of what women mean when they ask for “natural hormones” is already on it.

What you want	FDA-approved examples	Route and purpose
Body-identical estrogen through the skin	Estradiol patches such as Climara, Vivelle-Dot, Dotti, Minivelle, Lyllana, and generics	Systemic; used for eligible whole-body menopause indications
Body-identical estrogen as gel or spray	Divigel, EstroGel, Elestrin, Evamist, and generics where available	Systemic
Body-identical estrogen as a pill	Oral estradiol tablets	Systemic
Body-identical progesterone	Prometrium and generic micronized progesterone capsules	Systemic progestogen component; product and regimen matter
Estradiol and progesterone in one capsule	Bijuva	Systemic oral combination for its approved population and indication
A vaginal ring for systemic symptoms	Femring	Systemic despite being placed in the vagina; it is labeled for vasomotor symptoms and vulvar/vaginal atrophy
Low-dose estrogen for vaginal and urinary menopause symptoms	Estradiol vaginal cream, Vagifem/Yuvafem tablets, Imvexxy inserts, Estring	Local; not a substitute for systemic treatment of hot flashes
A local non-estrogen prescription for painful sex	Intrarosa (prasterone)	Local vaginal prescription; separate from systemic estrogen therapy

What is not available as an FDA-approved menopause product?

This list is where compounding questions become concrete.

• Estriol. FDA states that it has not approved any drug containing estriol. Any U.S. bi-est or tri-est product containing estriol is compounded and is not FDA-approved as a finished product.
• A combined estradiol-plus-progesterone vaginal cream. No FDA-approved product provides that combined vaginal dosage form. A clinician would still need a documented reason why an approved regimen cannot meet the patient's need before treating “custom” as a benefit by itself.
• Testosterone approved specifically for women. No testosterone product is FDA-approved specifically for women in the United States. Use in women is off-label or compounded. Testosterone is a Schedule III controlled substance, so a prescription and applicable controlled-substance rules always apply.
• Estradiol or testosterone pellets approved specifically for menopause treatment in women. Testosterone pellets are approved for certain male indications, not for menopause treatment in women. Compounded pellets used in women are not FDA-approved, and an implanted dose cannot be adjusted or stopped as simply as a pill, gel, or patch.

One current heads-up on estradiol patches

Estradiol transdermal systems have had manufacturer-specific supply problems in 2026. A shortage does not mean every patch, dose, or manufacturer is unavailable. Ask the pharmacy to check the exact strength and manufacturer before you leave the appointment.

We track the moving details in the estradiol patch shortage tracker and the 2026 patch shortage guide.

→ Does one of these look like what you were asking for? You are closer than you thought. The next step is matching the route to the symptom and the provider model to your insurance and state.

See which HRT route fits your situation →

Sources: FDA menopause guidance, DailyMed estradiol transdermal-system labeling, Prometrium labeling, Femring labeling, Estring labeling, Bijuva labeling, Intrarosa labeling, and 21 CFR 1308.13.

---

What is the difference between systemic and local hormone therapy?

Systemic hormone therapy reaches the bloodstream at levels intended to treat whole-body symptoms such as hot flashes and night sweats. Low-dose local vaginal estrogen is aimed at vaginal and urinary menopause symptoms. They are not interchangeable, and the word “vaginal” alone does not prove a product is local—Femring is systemic.

We are putting this before the compounding section on purpose. A woman who buys a low-dose vaginal cream for hot flashes may conclude that hormone therapy failed when what actually happened is that she bought the wrong category.

If your main problem is…	The category usually discussed	What the other category misses
Hot flashes, night sweats, and sleep disruption driven by vasomotor symptoms	Systemic estrogen—patch, gel, spray, tablet, or systemic ring	Low-dose local vaginal therapy does not treat vasomotor symptoms
Vaginal dryness, burning, painful sex, urinary urgency, or prevention of recurrent urinary infections after evaluation	Low-dose local vaginal estrogen—or another local prescription option	Systemic therapy may not provide enough local relief for every woman
Both systemic and vaginal/urinary symptoms	Sometimes both, based on clinician assessment	One category may cover only half the problem

Local does not mean weak. It means aimed. Low-dose vaginal products are designed for local treatment with low systemic exposure. Femring is the important exception: it is a vaginal ring that delivers systemic estradiol and is labeled for hot flashes.

If you have a uterus and use systemic estrogen, you generally need an adequate endometrial-protection plan, usually involving a progestogen unless your prescribed regimen works differently. Low-dose local vaginal estrogen is handled differently and generally does not require a progestogen solely because of that local use. The exact product and your history still control.

Sources: The Menopause Society on hormone therapy, Femring labeling, Estring labeling, and Vagifem labeling.

---

When are compounded bioidentical hormones appropriate?

Compounded hormone drugs are not FDA-approved, and FDA does not review their safety, effectiveness, or quality before marketing. Compounding can still meet a legitimate patient-specific need when an approved product cannot—especially a documented allergy to an ingredient or a documented need for a dosage form that is not available as an approved product.

Let us be precise, because this is where women get either scared off unfairly or sold something they do not need.

The National Academies' patient-specific test

The National Academies' 2020 review found that the evidence base for compounded bioidentical hormone therapy was limited and often relied on anecdotal claims, patient reports, and prescriber testimony rather than strong comparative trials. It recommended restricting use to patients with a documented allergy to an ingredient in an FDA-approved product or a documented need for a different dosage form.

ACOG's 2023 clinical consensus reaches the same practical conclusion: compounded bioidentical menopausal hormone therapy should not be prescribed routinely when FDA-approved formulations exist. The Endocrine Society also rejects claims that custom-compounded products are inherently safer or more effective.

Here is the test applied to real situations:

Your situation	Does it meet the patient-specific test?	What that means
You have a documented peanut allergy and the commercial progesterone product offered to you contains peanut oil	Potentially yes—ingredient allergy	Prometrium and multiple current generic progesterone labels list peanut oil. A verified peanut-free alternative may be a legitimate reason to compound. Midi publishes a compounded vegan, peanut-free progesterone option starting at $35 for 30 days, checked September 1, 2026. Verify your exact commercial manufacturer's excipients first.
You simply prefer estriol, bi-est, or tri-est	Not automatically	No FDA-approved estriol drug exists, so the product must be compounded. That explains the regulatory category; it does not establish a medical need or prove superiority.
You need a combined vaginal dosage form that no approved product provides	Potentially—if the need is documented	The missing dosage form can support compounding when a clinician documents why approved alternatives do not meet the need. “Custom sounds better” is not the same thing.
You need a dosage form you cannot use any other way because of an allergy, swallowing problem, or another documented limitation	Potentially yes	The specific need, unavailable approved alternative, pharmacy, dose, and monitoring plan should be recorded.
You want custom hormones because custom sounds more precise	No, not by itself	Routine customization claims are exactly what ACOG and the National Academies say the evidence does not support.
You prefer pellets because they are convenient	No, not by preference alone	Convenience does not establish a patient-specific need, and an implanted dose is harder to reverse if exposure is too high.

That is the honest map. Compounding is not automatically bad. It is also not a premium upgrade simply because the prescription is called custom.

Three questions that separate a defensible compounded prescription from a sales pitch

1. Which pharmacy or outsourcing facility prepares it, and is it operating under section 503A or 503B?

A section 503A pharmacy generally compounds for an identified patient under a prescription and remains subject to applicable state pharmacy oversight and federal conditions. A section 503B outsourcing facility registers with FDA, follows additional federal requirements including current good manufacturing practice, and may supply office stock as well as patient-specific prescriptions. Neither pathway makes a compounded drug FDA-approved.

“Not FDA-approved” does not mean “outside every law.” “Registered outsourcing facility” does not mean “FDA-approved product.” Both shortcuts are wrong.

2. What is the exact strength and amount delivered per dose?

Ask for milligrams or micrograms per measured dose—not “one click,” “one pump,” or “a pea-sized amount” without the strength behind it. A defensible prescription can answer this.

3. If you have a uterus and use systemic estrogen, what specifically protects the uterine lining?

This is where “natural versus approved” stops being a preference.

The uterine-lining question, stated plainly

Systemic estrogen without adequate opposition can stimulate the endometrium in a woman with a uterus. FDA retained the endometrial-cancer boxed warning on systemic estrogen-alone products during the 2026 labeling changes.

The 36-month trial in the FDA-approved Prometrium labeling makes the point better than an argument: endometrial hyperplasia occurred in 6% of women receiving conjugated estrogens plus micronized progesterone, compared with 64% receiving conjugated estrogens alone and 3% receiving placebo.

Now the part that matters for a progesterone cream. A systematic review concluded that transdermal micronized progesterone does not provide adequate endometrial protection. British Menopause Society guidance likewise warns that transdermal absorption is variable and that progesterone cream or gel should not be relied on for endometrial protection in menopausal hormone therapy.

If you have a uterus and use systemic estrogen, progesterone cream rubbed on the skin is not established as adequate protection for the uterine lining.

We are not softening that. If a provider proposes a combined body cream as your only estrogen-and-progesterone regimen, ask directly: “What specifically protects my uterine lining, what evidence supports this route, and how will it be monitored?” You are entitled to a specific answer.

For a deeper product-by-product comparison, read bioidentical HRT versus compounded HRT.

Sources: National Academies 2020 report, ACOG clinical consensus, FDA compounding questions and answers, Prometrium labeling, and systematic-review literature on micronized progesterone and the endometrium.

---

Are over-the-counter natural progesterone creams FDA-approved?

No FDA-approved OTC estrogen or progesterone cream exists for menopause treatment. Under 21 CFR 310.530, an OTC topical product marketed as containing estrogen, progesterone, pregnenolone, or another covered hormone for drug use is not recognized as safe and effective for that OTC use and requires an approved new-drug application.

This is one of the most useful checks on the page because it turns a federal regulation into something you can use while holding the jar.

What the federal rule says

The regulation is 21 CFR 310.530, “Topically applied hormone-containing drug products for over-the-counter human use.” It covers estrogens, progesterone, pregnenolone, and pregnenolone acetate in OTC topical drug products. It states that adequate effectiveness data are lacking for OTC drug use of those ingredients and that, outside the regulation's hydrocortisone exception, a covered product requires an approved application.

The rule also says that using the word hormone in labeling may itself imply a drug claim.

The ten-second shelf test

Pick up the jar. Look for an actual hormone name, a strength such as milligrams per pump, and a claim that it treats menopause symptoms or replaces a hormone. If the product makes that drug claim without being a prescription or an FDA-approved OTC drug: it is being marketed as an unapproved drug. If the product avoids a hormone-treatment claim: do not treat botanical, cosmetic, or “balance” language as proof that it provides hormone replacement. There is no lawful OTC shortcut where an unapproved cream can be marketed as estrogen or progesterone therapy simply by calling it natural.

Here is the limit of the test: the absence of hormone language does not prove a product has no biological effect. It proves that the label is not an approved promise of hormone replacement. That is the distinction you can actually rely on.

But it seemed to help my friend

Fair. Three honest possibilities, and we are not going to pick for her:

1. Some products contain an actual hormone and make an unapproved drug claim. Check the ingredient, strength, prescription status, and manufacturer rather than assuming every “wild yam” jar is the same.
2. Placebo responses in hot-flash trials are real. That is not an insult. It is one reason controlled trials are needed before a product gets credited for an effect.
3. Symptoms fluctuate. Hot flashes and sleep disruption can change over time, so something started during a bad stretch can look responsible for the next good one.

Sources: 21 CFR 310.530 and FDA menopause guidance.

---

Do natural remedies for menopause actually work?

The Menopause Society's 2023 evidence review does not recommend supplements or herbal remedies for vasomotor symptoms such as hot flashes. That category includes products built around black cohosh, soy extracts, equol, red clover, wild yam, and other botanicals. Evidence-based nonhormonal options exist, but the strongest list is not in the supplement aisle.

We want to be fair here because this is where many women feel judged.

Trying a supplement first is understandable. It feels accessible, low-commitment, and less likely to lead to an appointment where you might be dismissed. Nobody should feel foolish for trying it.

But you asked what the evidence says, so here it is.

Product or category	What it is sold for	What the evidence review says	What else matters
Black cohosh	Hot flashes and night sweats	Supplements and herbal remedies are not recommended for vasomotor symptoms; black-cohosh results are inconsistent	Products labeled black cohosh have been linked to rare cases of serious liver injury, although causality and product identity are sometimes uncertain
Soy foods, soy extracts, and S-equol	Hot flashes	Soy foods/extracts and equol are not recommended as vasomotor-symptom treatments	Soy can still be ordinary food; the conclusion is about using it as treatment
Red clover	Hot flashes	Falls within the not-recommended supplement/herbal category	Contains isoflavones; product composition and study results vary
Wild yam	“Natural progesterone”	Does not become progesterone in the human body; topical trial did not show meaningful benefit	A botanical source story is not hormone replacement
Dong quai, evening primrose, maca, flaxseed, and similar products	Various menopause symptoms	Evidence is insufficient, inconsistent, or negative within the not-recommended category	Supplements can interact with medicines and vary in content
Oral DHEA supplements	Energy, libido, or menopause symptoms	Not an FDA-approved menopause treatment; benefit and long-term safety are uncertain	Prescription vaginal prasterone is a different FDA-approved local product for a specific indication

The black-cohosh liver signal

This deserves its own paragraph because it is the clearest example of why natural is not a safety category.

NIH's LiverTox database, updated April 15, 2025, reports that products labeled as black cohosh have been implicated in clinically apparent acute liver injury, including severe cases. NCCIH provides the balancing detail: these reports are rare, causality is uncertain, and some products may have been misidentified or adulterated.

Both facts belong on the page. What does not belong is letting the word natural carry a safety promise it has not earned.

What the same society does recommend if you do not want hormones

The Menopause Society's evidence-supported options for vasomotor symptoms include:

• Cognitive behavioral therapy
• Clinical hypnosis
• SSRIs and SNRIs
• Gabapentin
• Fezolinetant (Veozah)
• Oxybutynin
• Weight loss for women for whom it is appropriate
• Stellate ganglion block in selected circumstances

Since that 2023 statement, FDA approved elinzanetant (Lynkuet) on October 24, 2025, for moderate-to-severe vasomotor symptoms due to menopause. Its current labeling calls for liver testing before treatment and again at three months. Fezolinetant also carries liver-related labeling and monitoring requirements.

If you are not going to use a hormone, this page will not try to talk you into one. That is a legitimate choice, and real options exist. The list above is where to start.

Read the full nonhormonal menopause options guide for product-level benefits, risks, and monitoring.

Sources: The Menopause Society 2023 nonhormone therapy position statement, NIH LiverTox: Black Cohosh, NCCIH on menopausal symptoms, Lynkuet labeling, and Veozah labeling.

---

Is natural hormone replacement therapy safer than regular HRT?

There is no good evidence that compounded bioidentical hormone therapy is safer than FDA-approved hormone therapy. Route, dose, timing, and the specific estrogen or progestogen can matter—but those are arguments for choosing an exact product and regimen, not for assuming that natural, custom, or compounded means safer.

We are going to give you both halves because most pages give only one.

The part that is not in dispute

The National Academies found that safety and effectiveness claims for compounded bioidentical hormone therapy often rested on low-quality evidence. ACOG says the marketing claims lack supporting evidence and advises against routine prescribing when FDA-approved formulations exist. FDA does not review compounded finished drugs for safety, effectiveness, or quality before marketing.

That is not three ways of saying “compounding is evil.” It is three authoritative sources saying the same narrow thing: the superiority claim has not been established.

The part almost every page skips

There are meaningful differences among hormone formulations. They just do not run along a natural-versus-synthetic line.

The French E3N cohort followed 80,377 postmenopausal women and documented 2,354 invasive breast cancers. Compared with never-use, the reported relative risk was 1.00 (95% CI 0.83–1.22) for estrogen plus progesterone, 1.16 (0.94–1.43) for estrogen plus dydrogesterone, and 1.69 (1.50–1.91) for estrogen plus other progestagens. The investigators did not find that the association differed by oral versus transdermal estrogen route in that analysis.

That is observational evidence, not a randomized trial and not an individual safety verdict. But it supports the point that the exact progestogen may matter. It does not show that a compounded product is safer.

FDA-approved transdermal estradiol and oral micronized progesterone already exist. You do not need a compounded label to discuss those formulation choices.

A compounded cream is not a dose-for-dose patch substitute

A 2023 study in Menopause compared estrogen exposure from compounded transdermal estradiol creams with FDA-approved estradiol patches and gels. Exposure from the compounded creams was dose-dependent but significantly lower than exposure from the approved transdermal products in the study.

Read that in both directions. It does not prove that a lower-exposure cream is safer, and it does not mean a cream and patch are interchangeable. Switching dosage form can change exposure even when the hormone name sounds familiar.

Sources: National Academies 2020 report, ACOG clinical consensus, E3N cohort study, and Newman et al. 2023.

---

What changed in FDA hormone-therapy labeling in 2026?

On February 12, 2026, FDA approved labeling changes for six menopausal hormone-therapy products, removing boxed-warning statements about cardiovascular disease, breast cancer, and probable dementia from those products. The action did not make hormone therapy risk-free, did not approve compounded products, and did not instantly rewrite every menopausal-hormone label.

What changed first

FDA said 29 drug companies submitted proposed labeling changes after the agency initiated the process in November 2025. The first six approvals announced February 12, 2026 were:

Product	Hormone type	Route/category
Prometrium	Micronized progesterone; body-identical	Oral progestogen
Divigel	Estradiol; body-identical	Systemic gel
Cenestin	Synthetic conjugated estrogens	Systemic oral estrogen
Enjuvia	Synthetic conjugated estrogens	Systemic oral estrogen
Estring	Estradiol; body-identical	Low-dose local vaginal ring
Bijuva	Estradiol plus progesterone; both body-identical	Systemic oral combination

Four of the first six products contain body-identical hormones: Prometrium, Divigel, Estring, and Bijuva.

What did not change

• Hormone therapy is still not appropriate for every woman.
• Product-specific contraindications, warnings, and precautions remain.
• FDA retained the endometrial-cancer boxed warning for systemic estrogen-alone products.
• Compounded products did not become FDA-approved. They were not part of the labeling process because they do not have FDA-approved prescribing information.
• Natural did not become a safety certification.

Why the rollout wording matters

As of September 1, 2026, FDA's public announcement identifies the first six approved label changes and describes a broader class process. Do not flatten that into “the black box was removed from HRT.” Check the current prescribing information for the exact product and manufacturer you receive.

The point almost nobody has made

For years, the compounded lane had a quiet selling point: our product does not come with that frightening boxed warning.

It did not come with one because compounded preparations do not have FDA-approved labeling at all.

The absence of a warning was never a safety finding. It was the absence of an FDA-reviewed label.

The 2026 action changed approved labeling based on FDA's review. It did not create a parallel review of compounded products. The approved product still arrives with product-specific prescribing information. The compounded product still does not.

Sources: FDA's February 12, 2026 announcement and FDA's February 13, 2026 consumer update.

---

Which natural HRT myths should you stop paying for?

Most natural-HRT claims contain a fragment of truth stretched past where the evidence goes. A hormone can be body-identical or manufactured from a plant precursor, and neither fact proves that the finished product is approved, correctly dosed, better absorbed, safer, or appropriate for you.

Claim	Verdict	What is actually true
“Bioidentical means compounded.”	False	FDA-approved products containing body-identical estradiol and micronized progesterone exist.
“Compounded means personalized, so it is safer.”	Unsupported leap	Compounding can meet a documented patient-specific need. FDA does not review the finished compounded product for safety, effectiveness, or quality before marketing.
“The ingredient is FDA-approved, so the cream is FDA-approved.”	False	Approval applies to a specific finished drug product—not every preparation containing a familiar hormone.
“Plant-derived means unprocessed.”	False	Plant precursors undergo pharmaceutical conversion and manufacturing. Source does not establish approval or safety.
“Wild yam turns into progesterone in my body.”	False	The conversion is industrial chemistry. The human body does not perform it.
“Premarin is natural, so it is body-identical.”	Half true and misleading	Its label describes natural sources, but the conjugated-estrogen mixture is not body-identical human estradiol.
“Over the counter means gentle.”	False	OTC or supplement status does not erase interactions, adverse effects, contamination, adulteration, or unlawful drug claims.
“Natural HRT has no cancer or clot risk.”	False	Risk depends on the exact product, route, dose, timing, age, uterus status, and health history. Natural is not a risk exemption.
“Blood or saliva testing will reveal my perfect custom dose.”	Unsupported for routine menopause dosing	Vasomotor-symptom treatment is generally guided by symptoms and response. Salivary hormone testing is not a validated basis for custom dosing.
“The 2026 FDA change removed every HRT warning.”	False	FDA first approved changes for six products; product-specific warnings remain, and systemic estrogen-alone products retain the endometrial-cancer boxed warning.

---

Who should start with an in-person visit instead of online care?

Online care may not be the right first step when your situation needs an examination, diagnostic workup, oncology input, or complex risk review. Unexplained postmenopausal bleeding, possible pregnancy, hormone-sensitive cancer, prior clot, stroke or heart attack, liver disease, or multiple interacting conditions deserve a clinician who can see the full record.

We would rather lose the click than send you into a five-minute intake when your situation needs an examination.

Please start in person if:

• You have bleeding after menopause or bleeding you cannot explain. This needs evaluation before starting a hormone product. Not later. First.
• You have a current or prior breast, uterine, or other hormone-sensitive cancer. The decision may need your oncology team and a clinician familiar with your records.
• You have had a blood clot, stroke, or heart attack. Eligibility and route both require individualized review.
• You have liver disease. This matters for prescription hormones and several nonhormonal or supplement options.
• You may be pregnant. Menopausal hormone therapy is not contraception, and pregnancy remains possible during perimenopause.
• You take medicines with meaningful interactions or manage several conditions at once. A fragmented online intake may not be enough.

None of that automatically means no. It means not by quiz alone.

If you may be having an emergency, call 911 or seek urgent in-person care. This page does not triage emergencies, and neither does the matching tool.

→ Not sure where your starting point belongs? Find My HRT Path is built to flag situations that should begin in person before you spend anything.

Check which starting point fits your history →

Sources: current FDA-approved estrogen and estrogen-progestogen labeling, FDA menopause guidance, and The Menopause Society on hormone therapy.

---

What does natural hormone replacement therapy cost?

Cost depends less on the word natural than on the care model. An FDA-approved prescription sent to a retail pharmacy separates the visit price from the medication price. A shipped program may bundle care and medication. Compounded products are usually cash-pay. The number that matters is the complete first-90-day and first-year cost.

One-time visits, memberships, pharmacy prices, and drug-inclusive subscriptions are not the same unit. Here is the only comparison that keeps those differences visible.

Route or program model	Published price checked September 1, 2026	What the number includes	Insurance and lab reality	What to verify before paying
Your own clinician + retail pharmacy	No universal price	Visit or copay, then the exact prescription at your pharmacy	Coverage depends on clinician network, drug formulary, manufacturer, strength, and deductible	Visit cost, exact drug/NDC, prior authorization, pharmacy price, and follow-up
Midi Health self-pay care	$250 initial · $150 follow-up	Clinical visit; medication and labs are separate	Midi says it is in network with many commercial PPO plans. It does not bill Medicare or Medicaid; Medicare beneficiaries may use self-pay but cannot submit the claim to Medicare, while Medicaid/Medi-Cal members are not eligible for Midi care even as self-pay	Your plan, state, lab orders, medication copay, and cancellation terms in scheduling
Midi Custom Rx peanut-free progesterone	Starts at $35 for 30 days	Compounded medication; cash-pay	Not an FDA-approved finished product; offered for a specific formulation need	Exact strength, Belmar pharmacy label, shipping, and whether an approved product can meet the need
Sesame menopause program	$59 per month	Ongoing clinical care and messaging; medication is separate	Cash-pay program. Sesame says basic labs may be included when clinically needed, with state and network exceptions. Its terms require users to certify they are not Medicare, Medicaid, or TRICARE beneficiaries	State availability, lab exception, pharmacy price, next billing date, and first-month refund terms
Winona progesterone capsules	$39 every 28 days	Provider-stated shipped product and care model	Cash-pay; Winona labels the capsules as FDA-approved, but the exact dispensed manufacturer/NDC was not shown on the public pages we checked before intake	Exact product/NDC, automatic processing date, and state eligibility
Winona estrogen tablets	$54 every 28 days	Provider-stated shipped product and care model	Cash-pay; Winona labels the tablets as FDA-approved, subject to confirmation of the exact product dispensed	Exact product/NDC, automatic processing date, and state eligibility
Winona body cream	$89 every 28 days	Compounded shipped medication and care model	Cash-pay; Winona labels the cream compounded	Ingredients, dose per click/pump, uterus-protection plan, pharmacy, and refund window
Winona estradiol patch	$149 every 28 days	Provider-stated shipped patch and care model	Cash-pay; Winona labels the patch FDA-approved, subject to confirmation of the exact product dispensed	Exact manufacturer/NDC, strength, inventory, next processing date, and refund window

Cost trap 1: a 28-day price is not a calendar-month price

Winona publishes a 28-day billing cycle. That produces about 13.04 charges per year, not 12.

A patch listed at $149 every 28 days works out to about $1,942.32 per 365-day year, or $161.86 per calendar month when annualized. The arithmetic is ours; the $149 price and 28-day interval are provider-stated facts checked September 1, 2026.

Cost trap 2: you may be comparing different things

A retail-pharmacy price is usually the drug alone. A telehealth visit price may cover care but not medication. A shipped program may bundle medication, prescribing, messaging, and delivery.

Putting those numbers beside each other without an “included” column is how a $59 care membership gets mistaken for a $59 total—and how a $149 drug-inclusive shipment gets mistaken for a pharmacy-only price.

Cost trap 3: the sticker price is not the first-90-day price

The useful formula is:

Initial care + follow-up care + medication + labs + shipping − confirmed insurance or discount = your real first-90-day cost.

We will not invent the part that depends on your plan, prescription, pharmacy, or lab network. Get the complete number before you hand over a card.

For a broader live comparison, use the online HRT cost guide.

Sources: provider-published pricing, insurance, lab, billing, and policy pages from Midi Health, Sesame, Sesame's terms, Winona, and Winona's help center, all checked September 1, 2026.

---

Where do you actually get body-identical hormones?

A clinician with prescribing authority can prescribe FDA-approved estradiol and micronized progesterone. You do not need a specialty “bioidentical hormone clinic” just to access body-identical hormones. Online providers mainly differ in insurance billing, pharmacy model, compounded-product use, state availability, labs, follow-up, and cancellation friction.

Let us put the most useful sentence on the page in bold:

You do not need a bioidentical hormone clinic to get body-identical hormones. FDA-approved estradiol and micronized progesterone are ordinary prescriptions that an appropriate prescriber can send to a pharmacy.

If your usual clinician is willing and knowledgeable, that may be the simplest and least expensive route. We would rather tell you that than sell you a subscription you did not need.

Online care becomes useful when your clinician will not prescribe, does not have menopause expertise, or cannot see you soon. Here is the provider-stated-versus-verified view.

Starting route	What the provider says it offers	What we independently verified	Insurance, labs, and payment	Availability and exit terms	Last checked
Your usual OB-GYN, primary-care clinician, or menopause specialist	Depends on clinician	FDA-approved estradiol and micronized progesterone products exist and can be prescribed when clinically appropriate	Insurance and pharmacy benefit may apply	Depends on clinician and health system	September 2026
Midi Health	FDA-approved prescriptions as its primary lane, plus a narrow Custom Rx compounded line	Published self-pay prices; many PPO relationships; prescriptions can go to the patient's pharmacy; Custom Rx names Belmar and publishes a peanut-free compounded progesterone option	$250 initial / $150 follow-up self-pay; medications and labs separate; plan coverage varies	Publishes nationwide clinician access; exact appointment-cancellation terms must be confirmed in scheduling	September 1, 2026
Sesame	Menopause care may include FDA-approved or compounded hormone prescriptions at clinician discretion	$59/month; medication separate; basic labs may be included with exceptions; no controlled substances prescribed online	Cash-pay; no insurance billing; federal-program beneficiary restriction in terms	Clinician availability is state-specific; initial-visit and renewal cancellation terms are published	September 1, 2026
Winona	A mixed catalog: provider-labeled FDA-approved patch, tablets, and progesterone capsules; compounded body and vaginal creams	Prices, 28-day billing, compounded badges, service-area list, and 24-hour post-processing refund window	Cash-pay; shipped program	Available in 37 states plus Puerto Rico on the published list; after 24 hours from order processing, the company says orders cannot be canceled, refunded, or returned	September 1, 2026

Provider-stated means the fact comes from the company's own current page. Independently verified means we matched a regulatory or labeling claim to FDA, DailyMed, eCFR, or another authoritative source. We did not see the exact NDC or manufacturer dispensed to an individual patient before intake, so we do not convert a provider's product badge into an independent product-level approval finding.

Affiliate disclosure before the first provider link

The HRT Index may earn a commission from some provider links on this page; see our affiliate disclosure. That commercial relationship does not change the product category: a compounded drug stays non-FDA-approved, and a provider's claim stays provider-stated until the exact product can be checked. We recommend the model that fits this question—not the option with the highest commission.

The insurance-first online route: Midi Health

For a reader whose priority is an FDA-approved prescription sent to a pharmacy with possible commercial-insurance billing, Midi is the strongest online fit among the models reviewed here.

Midi publishes self-pay prices of $250 for an initial visit and $150 for follow-ups and says it works with many PPO plans. Its clinicians can send prescriptions to the patient's own pharmacy. That means the exact medication can be processed through the patient's pharmacy benefit when covered, and the prescription is not automatically tied to a shipped subscription.

Midi also has a compounded Custom Rx line. That matters because “check the product, not the brand” applies even to the provider we recommend. Its published peanut-free progesterone starts at $35 for a 30-day supply, is described as vegan and peanut-free, and is compounded by Belmar. That is a plausible example of compounding used to address an excipient problem—not evidence that compounded progesterone is generally better.

Two short access-and-attention comments on Midi's own site illustrate the appeal without being used as treatment evidence:

“I signed up and had a visit the next day.” — Katherine G., provider-published testimonial Her clinician “understood the nuances of perimenopause & provided options.” — Pamela S., provider-published testimonial

These are individual experiences selected and published by Midi, not independently verified outcomes and not evidence of medical effectiveness.

The honest downside, before we ask you to click

Midi is not a compounding-first clinic and does not offer the broad bi-est, pellet, or custom-formula menu a compounding-first practice does. If that menu is your priority, a compounding-first provider is a better fit.

But because Midi's standard lane starts with commercially manufactured prescriptions and sends them to a pharmacy, eligible patients may use insurance, receive the exact manufacturer's labeling, and keep the medication decision separate from a recurring shipped-product program. Its narrow Custom Rx line remains a separate, clearly compounded category.

→ If you want body-identical hormones through a pharmacy-and-insurance model rather than a bundled cream subscription, this is the lane Midi is built for. Confirm your plan and state before booking.

The cash-pay care route: Sesame

Sesame's current menopause program is not a $34 one-off visit. It is $59 per month, medication separate. The program includes ongoing clinical care and messaging, and its page says basic labs may be included when clinically needed, subject to state and network exceptions.

Sesame also does not promise an FDA-approved-only lane. Its menopause page says a clinician may prescribe FDA-approved or compounded bioidentical hormone therapy. Ask for the exact product before assuming which category you will receive.

Three hard limits matter:

• Sesame does not bill insurance for the care program.
• Its terms require users to certify that they are not Medicare, Medicaid, or TRICARE beneficiaries.
• Sesame says controlled substances are not prescribed online, so this is not an online testosterone-prescribing route.

For cancellation, Sesame says a patient can receive a full refund before the first visit when the appointment is canceled at least three hours in advance; after the first visit, the first month is not refundable. Future billing must be canceled before the next renewal.

→ If you are paying cash and want a prescription sent to your own pharmacy, Sesame's model can fit—but compare the $59 care fee plus the medication, not the care fee alone.

See Sesame's current menopause-program terms →

The shipped-to-you route: Winona

Winona sells both lanes. Its current product pages label the estradiol patch, estrogen tablets, and progesterone capsules as FDA-approved options, while its body and vaginal creams are labeled compounded.

On this page, the FDA-approved lane is the relevant one for a woman who simply wants body-identical estradiol or progesterone. The compounded creams are a different regulatory category and should not be presented as equivalent.

Four things can decide this before price does:

• Winona bills every 28 days, not every calendar month.
• It publishes availability in 37 states plus Puerto Rico, not nationwide.
• Its refund window is 24 hours after an order processes. After that, the company says the order cannot be canceled, refunded, or returned.
• The exact commercial manufacturer and NDC were not shown on the public pages we checked before intake. If FDA approval is the reason you are choosing a patch, tablet, or capsule, ask for those details before the order processes.

There is also a wording problem worth knowing. The body-cream FAQ said its active ingredients were FDA-approved while listing estriol, even though no estriol-containing drug is FDA-approved. The page's separate compounded badge gives the correct finished-product category. That is why you should use the badge and exact product—not the ingredient reassurance—to make the decision.

→ If you want an estradiol patch or progesterone capsule shipped without using insurance, ask Winona for the exact manufacturer, NDC, strength, 28-day charge, and processing date before you authorize the order.

See Winona's current availability and product pages →

Why Hers is not a commercial recommendation on this page

On July 29, 2026, the FTC, California, and Utah filed an action against Hims & Hers alleging deceptive billing, cancellation, and privacy practices. Hims & Hers publicly disputes the allegations. The matter was pending when we checked it on September 1, 2026.

Those are allegations, not findings. We are not using Hers as a commercial recommendation on this page while the case is unresolved, and we are telling you why.

Provider sources: Midi pricing and insurance, Sesame menopause treatment, Sesame terms, Winona, Winona help center, and the FTC Hims & Hers matter, checked September 1, 2026.

---

What should you verify before you pay for natural HRT?

Get product-level answers before you hand over a card: exact drug, finished-product FDA status, route, pharmacy, reason for compounding, uterus-protection plan, full first-90-day cost, follow-up, state eligibility, and cancellation date. If a seller cannot answer those clearly, natural is not a reason to proceed.

Ten questions. Copy them. Use them with any provider, including the ones we name.

1. What is the exact finished-product name, active ingredient, strength, dosage form, manufacturer, and NDC if commercially manufactured?
2. Is the finished product FDA-approved, compounded, a dietary supplement, or a cosmetic?
3. Is it systemic or local, and which symptom is it meant to treat?
4. If it is compounded, what documented need can an FDA-approved product not meet?
5. Which pharmacy or outsourcing facility prepares or dispenses it, and is it operating under 503A or 503B?
6. If I have a uterus and use systemic estrogen, what provides adequate endometrial protection and how will that plan be monitored?
7. What follow-up, dose adjustment, refill, and between-visit messaging are included?
8. What is the complete first-90-day cost—initial visit, follow-up, membership, medication, labs, shipping, and any automatic renewal?
9. What is my next processing or billing date, and how do cancellation, refunds, refills, pauses, and prescription transfers work?
10. What in my history means I should be examined or treated in person first?

Two notes on using them.

Question 4 is not an accusation. A good answer can be one sentence: “The approved capsule available to you contains an excipient you are allergic to, so we need a different formulation.” That is a patient-specific reason. “Custom is always better” is not.

Question 9 prevents avoidable charges. Cancel-anytime and refund-anytime are not the same promise. Find the next processing date before you cancel anything.

→ Use the list before you book. Find My HRT Path can narrow the route, insurance model, state availability, and safety starting point so you enter the consult knowing what to ask.

Match your situation before you book →

---

What should you ask at your first HRT appointment?

Name the decision instead of repeating the category. “I want natural hormones” leaves every important question unanswered. “I want to discuss body-identical estradiol, I prefer a transdermal route, and I need to know whether I require progesterone” starts a real clinical conversation.

Print this or save it to your phone.

Treatment fit

• Which symptom are we treating first?
• Is this systemic or local treatment?
• What would count as meaningful improvement, and when will we reassess?
• What symptoms would mean I should contact you sooner?

Product identity

• Can we discuss FDA-approved body-identical estradiol and micronized progesterone before a compounded option?
• Is the exact product FDA-approved or compounded? What are the manufacturer, strength, dosage form, and pharmacy?
• If compounded, what documented need does it solve?
• What inactive ingredients matter for my allergies? Prometrium and multiple current generic progesterone capsule labels list peanut oil, so the exact manufacturer matters.

Route and my body

• Which route—patch, gel, spray, ring, vaginal product, or oral—fits my symptoms and history, and why?
• I have or do not have a uterus. What is the endometrial-protection plan?
• What in my personal and family history changes the benefit-risk discussion?
• Do I need contraception during perimenopause in addition to symptom treatment?

Follow-up and control

• Who answers questions between visits?
• How are side effects, dose changes, and refills handled?
• Can the prescription be transferred to another pharmacy or clinician?
• Which symptoms require urgent care rather than a portal message?

Cost and exit

• Will the visit, medication, and labs be covered separately?
• What is the complete first-90-day cost?
• When is the next automatic charge or order-processing date?
• How do I pause, switch, transfer, or cancel?

---

What did The HRT Index actually verify for this page?

We reviewed the exact regulatory category, product labeling, society guidance, peer-reviewed evidence, and provider commercial terms used in the article. We did not buy, use, prescribe, or clinically test any hormone product, and we do not claim firsthand patient experience.

Verified from authoritative sources in September 2026

• FDA's menopause and compounding guidance, including the statement that no FDA-approved drug contains estriol.
• The February 12, 2026 FDA labeling action and the six named products.
• Current labeling for Premarin, Prometrium, estradiol transdermal systems, Femring, Estring, Bijuva, Vagifem, and Intrarosa.
• 21 CFR 310.530 on OTC topical hormone-containing drug products.
• 21 CFR 1308.13 on Schedule III anabolic steroids, including testosterone.
• The National Academies' 2020 compounded-bioidentical review and patient-specific recommendation.
• ACOG and Endocrine Society positions on compounded bioidentical hormone therapy.
• The Menopause Society's hormone-therapy and 2023 nonhormone-therapy materials.
• Peer-reviewed evidence used for wild yam, endometrial protection, the E3N cohort, and compounded cream exposure.
• NIH LiverTox and NCCIH material on black cohosh.

Verified from provider-published sources on September 1, 2026

• Midi's self-pay visit prices, insurance framing, pharmacy model, named Custom Rx compounder, and published peanut-free progesterone price.
• Sesame's $59 monthly program price, medication separation, lab framing, controlled-substance restriction, federal-program terms, and cancellation language.
• Winona's product prices, 28-day billing interval, product-level FDA-approved/compounded badges, service-area list, and 24-hour post-processing refund window.
• The Winona body-cream FAQ wording about FDA-approved ingredients and its separate compounded badge.
• The pending FTC action involving Hims & Hers and the company's public denial.

What we could not verify before an individual intake

• The exact manufacturer or NDC a telehealth provider will dispense to a specific patient.
• A patient's insurer allowance, deductible, pharmacy copay, prior authorization, or lab-network charge.
• Inventory at a particular pharmacy on a particular day.
• The clinical decision a licensed prescriber will make after reviewing an individual history.
• A provider policy shown only inside a logged-in checkout or appointment flow.

That is why product-level language on this page says provider-stated until an exact commercial product can be matched to FDA or DailyMed.

How we review providers

The HRT Index Verification Standard is the documented process used to review providers: read every published price, separate FDA-approved from compounded products, verify state availability and insurance, and re-check on a fixed schedule—top providers monthly and the full roster quarterly.

Every provider comparison uses the same five pillars, in this order: clinical legitimacy, care quality, medication fit, price transparency, access.

We do not assign numeric provider scores. The underlying decision changes by symptoms, route, insurance, history, and state, so a single invented number would conceal the facts that actually determine fit.

Why the testimonials are limited

We used two short provider-published comments about access and feeling heard. We did not use a testimonial to support safety, effectiveness, or a treatment outcome.

The evidence problem around compounded-hormone superiority is already built from anecdotes. Adding one more outcome story would not improve the decision.

We also earn commissions from some providers named here. The primary online recommendation follows the FDA-approved and insurance-sensitive intent of this page rather than forcing a compounded offer into the answer.

Found something wrong? Email partners@thehrtindex.com. We publish corrections and update the visible verification date when a material fact changes.

---

Frequently asked questions

Is bioidentical hormone therapy the same as natural hormone therapy?

Not exactly. Bioidentical describes a hormone molecule with the same structure as one the human body makes. Natural can describe a source story, a compounded prescription, an OTC product, or a supplement containing no hormone. Neither word tells you whether the finished product is FDA-approved.

What is the most natural form of hormone replacement therapy?

There is no regulated “most natural” ranking. If you mean the closest molecular match to ovarian hormones, FDA-approved products containing estradiol and micronized progesterone fit that description. If you mean unprocessed, no hormone medicine qualifies; all finished hormone products are manufactured.

Are natural hormones safer than synthetic hormones?

Natural is not a safety category. Product, dose, route, timing, age, uterus status, and health history matter. There is no good evidence that custom-compounded bioidentical hormones are safer than FDA-approved hormone therapy.

Can I get natural hormone replacement therapy without a prescription?

Not as approved hormone replacement therapy. Estrogen, progesterone, and testosterone hormone treatment requires a prescription. No FDA-approved OTC estrogen or progesterone cream exists for menopause treatment, and testosterone is a Schedule III controlled substance.

Is natural HRT covered by insurance?

FDA-approved commercially manufactured prescriptions may be covered when they are on the plan's formulary and the prescriber/pharmacy requirements are met. Compounded products are usually cash-pay and often excluded, but plan rules vary. Ask about the exact product rather than the word natural.

What is the difference between estradiol and Premarin?

Estradiol products contain the same molecular form as human estradiol. Premarin is a conjugated-estrogen mixture derived from pregnant mares' urine and includes equilin, which is not a human estrogen. Both product categories can be FDA-approved; only estradiol is body-identical.

Is compounded hormone therapy dangerous?

Not automatically, and compounding can meet a documented patient-specific need. The problem is that FDA does not review the finished compounded drug for safety, effectiveness, or quality before marketing, and evidence does not support routine claims that compounded bioidentical therapy is safer or more effective than approved options.

Do I need progesterone if I use natural estrogen?

If you have a uterus and use systemic estrogen, you generally need adequate endometrial protection, usually with a progestogen unless your prescribed regimen works differently. Low-dose local vaginal estrogen is handled differently. Your exact product, route, and history decide the plan.

Does wild yam cream raise progesterone?

No evidence shows that the human body converts wild-yam diosgenin into progesterone. A placebo-controlled trial of topical wild-yam extract found no meaningful change in menopause symptoms or sex-hormone levels.

Does black cohosh work for hot flashes?

The Menopause Society's 2023 review does not recommend supplements or herbal remedies for vasomotor symptoms, and black-cohosh evidence is inconsistent. Rare serious liver-injury reports also exist, although causality and product identity are not always certain.

What can I use for hot flashes if I do not want hormones?

Evidence-supported options include cognitive behavioral therapy, clinical hypnosis, certain SSRIs or SNRIs, gabapentin, fezolinetant, oxybutynin, and selected interventions such as weight loss or stellate ganglion block. Elinzanetant was FDA-approved in October 2025. Prescription choices have their own contraindications and monitoring.

Do I need blood or saliva testing to find my HRT dose?

Routine treatment of vasomotor symptoms is generally guided by symptoms and clinical response rather than a promised “perfect” hormone number. Salivary hormone testing is not a validated basis for custom dosing. Testing may still be appropriate when a clinician is evaluating another diagnosis or a specific clinical question.

How long does hormone therapy take to work?

Response time depends on the symptom, product, dose, and route. Do not let a seller promise a fixed deadline. Agree on a follow-up point when treatment starts, contact the prescriber sooner for concerning effects, and reassess the diagnosis, route, or dose if the expected benefit is not clear by that follow-up.

Is natural hormone replacement therapy the same as HRT?

Sometimes it is standard HRT wearing a different word. If the product is FDA-approved estradiol or micronized progesterone, it is conventional prescription hormone therapy and also body-identical. If it is an herbal supplement, it is not hormone replacement therapy at all.

Is testosterone part of natural hormone replacement therapy for women?

It may be marketed that way, but no testosterone product is FDA-approved specifically for women in the United States. Testosterone is Schedule III, always requires a prescription, and is used in women off-label or as a compounded drug after an individualized clinical decision. “Natural” does not reduce the controlled-substance requirement.

---

Where this leaves you

If you take one thing from this page, take this:

Natural was never the useful question. “What is the finished product, what route is it, and who checked it?” is.

For many women, the answer is better than expected. Body-identical estradiol and micronized progesterone already exist as FDA-approved prescriptions. You may not need a special natural-hormone clinic or a custom cream. You may need better words at your next appointment.

You were right to care about what goes in your body. Now you have the vocabulary to ask for it properly.

Still not sure which HRT program is right for you? Use the free matching tool to see which starting path fits your symptoms, route preference, insurance model, state, and safety flags.

Find My HRT Path →

---

Sources

1. U.S. Food and Drug Administration. Menopause.
2. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers.
3. U.S. Food and Drug Administration. FDA Approves Labeling Changes to Menopausal Hormone Therapy Products, February 12, 2026.
4. U.S. Food and Drug Administration. Hormone Replacement Therapies Can Help Women with Bothersome Menopausal Symptoms, February 13, 2026.
5. National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy, 2020.
6. American College of Obstetricians and Gynecologists. Compounded Bioidentical Menopausal Hormone Therapy, 2023.
7. Endocrine Society. Compounded Bioidentical Hormone Therapy.
8. The Menopause Society. Hormone Therapy.
9. The Menopause Society. 2023 Nonhormone Therapy Position Statement.
10. Electronic Code of Federal Regulations. 21 CFR 310.530—Topically applied hormone-containing OTC drug products.
11. Electronic Code of Federal Regulations. 21 CFR 1308.13—Schedule III.
12. DailyMed. Premarin labeling.
13. DailyMed. Prometrium labeling.
14. DailyMed. Estradiol transdermal-system labeling.
15. DailyMed. Vagifem labeling.
16. DailyMed. Femring, Estring, Bijuva, and Intrarosa labeling.
17. Komesaroff PA, et al. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones. Climacteric. 2001.
18. Fournier A, et al. Unequal risks for breast cancer associated with different hormone replacement therapies: E3N cohort. Breast Cancer Research and Treatment. 2008.
19. Newman MS, et al. Comparative estrogen exposure from compounded estradiol creams and FDA-approved patches and gels. Menopause. 2023.
20. Stute P, et al. Micronized progesterone and endometrial protection. Climacteric. 2016.
21. National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Black Cohosh, updated April 15, 2025.
22. National Center for Complementary and Integrative Health. Menopausal Symptoms: In Depth.
23. Memorial Sloan Kettering Cancer Center. Wild Yam.
24. Provider first-party sources. Midi Health pricing and insurance, Sesame menopause treatment, Sesame terms, Winona, and Winona help center, checked September 1, 2026.
25. Federal Trade Commission. Hims & Hers Health matter, checked September 1, 2026.

Educational content only. Not medical advice. Do not start, stop, or change hormone therapy without a licensed clinician who has reviewed your history.